A "Man Van" deployed in disadvantaged communities can help identify men at high risk for prostate cancer, according to a ...

PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.

Motorcycle manufacturer Harley-Davidson is now offering men a free prostate cancer blood test with every 800km bike service ...

Cases of colorectal, breast and prostate cancer have soared in Slovakia, with doctors diagnosing 62 percent more cases than two decades ago. Experts cite an ageing population, sedentary lifestyles, ...

Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030Ramat Gan, Israel, Feb. 18, 2025 (GLOBE ...

Serum testosterone (T) recovery to normal levels is associated with a significant improvement in overall survival in patients ...

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.

The PORTOS assay could indicate when or when not to offer dose-escalated radiation for localized prostate cancer.

TUESDAY, Feb. 18, 2025 (HealthDay News) -- A mobile "Man Van" screening program detected dozens of prostate cancer cases in ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S. bladder cancer patient registry at the 2025 American Society of Clinical ...